The Surgical Management of Proximal Femoral Metastases: A Narrative Review.
Daniel Axelrod, Aaron M Gazendam, Michelle Ghert
https://pubmed.ncbi.nlm.nih.gov/34677238/Actively Recruiting
Led by Michelle Ghert, MD · Updated on 2026-07-08
334
Participants Needed
13
Research Sites
52 weeks
Total Duration
Researchers are investigating treatments for patients with metastatic bone disease affecting the proximal femur, a common site of cancer spread to the skeleton that impacts mobility and quality of life. This randomized controlled trial compares two surgical approaches to stabilize or replace the affected hip bone, aiming to find out whether removing and reconstructing the bone leads to better patient outcomes than using metal hardware for stabilization. Participants will be randomly assigned to one of two treatment groups one group will receive internal fixation using metal rods, plates, or screws to stabilize the bone, while the other group will undergo resection of the affected bone followed by endoprosthetic reconstruction, which may include hip replacement. Surgical specifics such as the type of implant, approach, and use of additional disease control methods will be decided by the surgeon. This trial explores whether the more invasive reconstruction surgery reduces cancer recurrence and mechanical failure compared to internal fixation. During the study, participants will have follow-up visits at 2 weeks, 6 weeks, 4 months, 6 months, 9 months, and 12 months after surgery to monitor their progress. Researchers will assess mortality, physical function, and days spent at home over one year following surgery, along with quality of life measures. These evaluations will help determine which surgical method provides better outcomes for patients living longer with metastatic bone disease.
CONDITIONS
Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial
O
Olivia Virag, MA
H
Hadia Farrukh
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Michelle Ghert, MD
Lead Sponsor
Canadian Cancer Society (CCS)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Resection and reconstruction | Internal fixation | Standard guideline-supported surgical approach |
|---|---|---|---|
| What it is | Surgical removal of metastatic bone disease in the proximal femur followed by reconstructive procedures such as endoprosthetic replacement. | Stabilization of the affected proximal femur using internal fixation devices, typically nails or plates, without fully removing the bone lesion. | Current guideline-supported options include either resection with reconstruction or internal fixation, chosen based on extent of bone loss, patient prognosis, and lesion location. |
| Role in the trial | Investigational surgical arm to evaluate effectiveness in outcomes such as survival, physical function, and days at home. | Active comparator surgical arm to assess outcomes parallel to the investigational arm. | Represents current standard decision-making for eligible patients with metastatic bone disease of the proximal femur. |
| Primary use | Aims to surgically address metastatic bone lesions, restore function, and prolong mobility by removing the tumor and reconstructing the femur. | Provides structural stability to the femur and enables patients to mobilize shortly after surgery without full lesion excision. | Guidelines allow for either full resection and reconstruction or internal fixation based on bone loss and projected life expectancy, aiming to balance tumor control, mobility, and surgical risk. |
| How it is given or performed | Performed as open surgery, removing the affected bone and replacing it with a prosthesis or reconstructive device. | Surgical stabilisation via internal fixation devices, typically through minimally invasive or open procedural techniques. | Guidelines recommend surgical technique based on lesion characteristics: internal fixation for moderate bone loss; resection and reconstruction for extensive destruction or high instability. |
| Evidence status | Ongoing investigation; current published evidence suggests benefit in long-term durability and functional restoration for extensive bone loss. | Ongoing investigation; published evidence indicates quicker surgery and shorter initial recovery, but possible higher risk for revision in cases of extensive bone loss. | Guidelines are based on clinical studies showing efficacy for both approaches with choice depending on patient-specific and lesion-specific factors. |
| Important limitations | Requires major surgery; carries substantial risks of perioperative morbidity, infection, prosthesis failure, and prolonged recovery. | Offers less invasive surgery and shorter initial hospital stay, but may be prone to hardware failure if bone loss is extensive or patient survival is long. | Guidelines note that choice between procedures should be individualized; both have tradeoffs in surgical risk, durability, and recovery, with no one-size-fits-all solution. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo one of two surgeries: internal fixation using metal hardware to stabilize the bone or removal and reconstruction of the affected proximal femur with an endoprosthesis.
Surgery day visit
Duration - 12 months
Participants attend follow-up appointments at 2 weeks, 6 weeks, 4 months, 6 months, 9 months, and 12 months after surgery to monitor recovery and outcomes.
6 follow-up visits
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Daniel Axelrod, Aaron M Gazendam, Michelle Ghert
https://pubmed.ncbi.nlm.nih.gov/34677238/Michelle Ghert, MD
Lead Sponsor
Canadian Cancer Society (CCS)
Collaborating Sponsor